Provided by Tiger Fintech (Singapore) Pte. Ltd.

Loews

88.11
+1.802.09%
Post-market: 88.110.00000.00%16:29 EDT
Volume:519.40K
Turnover:45.65M
Market Cap:18.53B
PE:13.75
High:88.33
Open:87.33
Low:86.97
Close:86.31
Loading ...

New Found Gold Corp. Provides Queensway Gold Project Overview and Plans; Files Technical Report

CNW Group
·
16 Apr

Loews Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

GE2025: No target vote share in mind with fierce contest expected in coming election, says PM Wong

CNA
·
12 Apr

Loews Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
11 Apr

Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025

GlobeNewswire
·
10 Apr

Loews Corporation's (NYSE:L) US$2.3b market value fall may be overlooked by institutional investors after a year of 8.7% returns

Simply Wall St.
·
09 Apr

Loews Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
08 Apr

Loews Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
05 Apr

FDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofAS

Yahoo Finance
·
04 Apr

Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients

GlobeNewswire
·
01 Apr

Loews Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
01 Apr

TIVDAK® (tisotumab vedotin) Approved by European Commission for Previously Treated Recurrent or Metastatic Cervical Cancer

GlobeNewswire
·
31 Mar

Labour’s Employment Rights Bill is a howler that will hammer jobs

cityam
·
31 Mar

Press Release: Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Dow Jones
·
31 Mar

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

GlobeNewswire
·
28 Mar

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

GlobeNewswire
·
28 Mar

Candel Therapeutics Reports Prolonged Survival In Mid-Stage Study For Pretreated Lung Cancer Patients

Benzinga
·
28 Mar

Press Release: Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine Strong Outlook for 2025

Dow Jones
·
28 Mar

Ferrari's luxury cars are about to get more expensive, thanks to Trump's tariffs

Quartz
·
27 Mar

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

Business Wire
·
27 Mar